Table 4

Relation between continuity of care and medication adherence
Medication adherence
17 or less 18 19 20 (maximum)
Personal continuity in general practice (p < 0.01)
0 care providers 4 (2.6%) 5 (3.2%) 28 (17.9%) 119 (76.3%)
1 care provider 9 (12.0%) 6 (8.0%) 5 (6.7%) 55 (73.3%)
2 care providers 1 (2.4%) 5 (12.2%) 4 (9.8%) 31 (75.6%)
3 or more care providers 0 (0.0%) 4 (16.7%) 4 (16.7%) 16 (66.7%)
Team continuity in general practice (p = 0.04)
30 3 (3.0%) 4 (4.0%) 11 (11.1%) 81 (81.8%)
24-29 5 (5.3%) 8 (8.5%) 15 (16.0%) 66 (70.2%)
18-23 3 (9.7%) 6 (19.4%) 6 (19.4%) 16 (51.6%)
12-17 3 (17.6%) 0 (0.0%) 1 (5.9%) 13 (76.5%)
6-11 0 (0.0%) 2 (11.8%) 3 (17.6%) 12 (70.6%)
Cross-boundary continuity (p = 0.19)
20 2 (2.1%) 3 (3.1%) 14 (14.6%) 77 (80.2%)
16-19 3 (6.1%) 4 (8.2%) 10 (20.4%) 32 (65.3%)
12-15 1 (4.3%) 3 (13.0%) 2 (8.7%) 17 (73.9%)
8-11 0 (0.0%) 3 (25.0%) 1 (8.3%) 8 (66.7%)
4-7 1 (11.1%) 0 (0.0%) 1 (11.1%) 7 (77.8%)

Medication adherence varied between 4 (minimum) and 20 (maximum). Because of the small number of patients scoring 17 or less, we grouped these patients together.

Uijen et al.

Uijen et al. BMC Family Practice 2012 13:86   doi:10.1186/1471-2296-13-86

Open Data